DLL4 and nonpapillary renal cell carcinoma: More importantly, we identified DLL4/Notch and JAG/Notch signaling as the key ligand-receptor pairs involved in ligand‒receptor interactions in ccRCC, which might disrupt angiogenesis to reduce tumor growth and metastasis (Kangsamaksin et al., 2015).